No Data
No Data
Guggenheim Initiates Unicycive Therapeutics(UNCY.US) With Buy Rating, Announces Target Price $6
Guggenheim Initiates Unicycive Therapeutics at Buy With $6 Price Target
Benchmark Co. Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Maintains Target Price $3
Express News | HC Wainwright & Co. Reiterates Buy on Unicycive Therapeutics, Maintains $7.5 Price Target
Unicycive Therapeutics: Buy Rating on Imminent FDA Approval and Market Potential of Oxylanthanum Carbonate
Express News | Unicycive Announces Presentation Of Patient-Reported Outcomes From Phase 2 OLC Study